Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating DNA Microsatellites: Molecular Determinants of Response to Biochemotherapy in Patients With Metastatic Melanoma

20 Jan 2004

Abstract excerpt

Although biochemotherapy appears to be a promising treatment for metastatic melanoma, its impact remains unpredictable. Microsatellite markers for loss of heterozygosity (LOH) appear to have prognostic significance when identified in primary tumors and serum and/or plasma from cancer patients. However, their association with response to systemic therapy has yet to be assessed. To determine whether microsatellite...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14734706
DOI: 10.1093/jnci/djh011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating DNA Microsatellites: Molecular Determinants of Response to Biochemotherapy in Patients With Metastatic MelanomaPMID 14734706Read ↗

Association of Circulating Tumor Cells with Serum Tumor-Related Methylated DNA in Peripheral Blood of Melanoma PatientsSemantic proximity Read ↗

Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy.Semantic proximity Read ↗

Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome.Semantic proximity Read ↗

Molecular markers of circulating melanoma cells.Semantic proximity Read ↗

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report.Semantic proximity Read ↗

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting.Semantic proximity Read ↗

The Role of Microsatellites as a Prognostic Factor in Primary Malignant MelanomaSemantic proximity Read ↗

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.Semantic proximity Read ↗

Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.Semantic proximity Read ↗

Microsatellite alterations plasma DNA of primary breast cancer patients.Semantic proximity Read ↗

Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation.Semantic proximity Read ↗

A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.